1990年至2021年帕金森病的全球负担:一个基于人口的研究研究
Mimi Li1, Xiaofang Ye1, Zhengping Huang1
1Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
BMJ open
|April 27, 2025
概括
从1990年到2021年,帕金森病 (PD) 的负担在全球范围内增加,男性的发病率更高. 这一趋势凸显了改善PD管理策略的迫切需要,特别是全球人口老龄化.
科学领域:
- 神经学 神经学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 帕金森病 (PD) 构成了日益严重的公共卫生挑战,全球人口老龄化加剧了这一问题.
- 了解PD的流行病学趋势对于有效的公共卫生干预至关重要.
研究的目的:
- 从1990年到2021年,在国家,区域和全球层面预测帕金森病 (PD) 的负担和趋势.
- 在此期间分析PD的发病率,患病率,死亡率和残疾调整寿命年 (DALYs).
主要方法:
- 利用2021年全球疾病负担 (GBD) 数据进行了基于人口的综合性研究.
- 雇佣年龄标准化率 (ASR) 和估计年百分比变化 (EAPC) 来分析从1990年到2021年的趋势.
- 应用贝叶斯年龄周期队列模型来预测未来的PD趋势,直到2046年.
主要成果:
- 在全球范围内,PD发病率,患病率,DALY和死亡率的年龄标准化率在1990年至2021年之间呈现出增长趋势.
- 与女性相比,男性的发病率,流行率,死亡率和DALY率始终较高,性别差距随着年龄的增长而扩大.
- 在特定国家观察到PD负担的显著增加,包括挪威,莱索托和阿拉伯联合长国,预测表明全球流行率持续上升.
结论:
- 该研究显示,从1990年到2021年,大多数全球地区的帕金森病 (PD) 患病率和负担显著增加.
- 调查结果强调了加强PD管理和控制策略的关键需求,特别是考虑到人口向人口老龄化趋势的变化.
更多相关视频
07:32Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model
Published on: December 28, 2021
3.0K
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.3K
相关概念视频
Parkinson's Disease: Overview
308
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
308
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Single Nucleotide Polymorphisms-SNPs
13.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.6K
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
EPS and iPS Cells in Disease Research
2.7K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.7K
